Search Results

FBC-funded researcher studies photoreceptor cell metabolism in RP

Fighting Blindness Canada (FBC) is pleased to be supporting Dr. Peter Campochiaro’s (Wilmer Eye Institute, John Hopkins University) research into retinitis pigmentosa (RP). Dr. Campochiaro is a world-renowned clinician-scientist whose research program...

NEWLY DIAGNOSED WITH AN EYE DISEASE

Being diagnosed with an eye disease can be confusing and scary. You may have a lot of questions or, you may not know what questions to ask. This page shares helpful information...

HOW THE EYE WORKS

Light rays enter the eye through the cornea—the clear surface of the eye. The shape of the cornea bends light rays so they can enter the pupil. The iris is the coloured...

AN INTRODUCTION TO PATIENT ADVISORY GROUPS

At Fighting Blindness Canada, we often connect with pharmaceutical companies who are developing treatments for blinding eye diseases and are working to understand the patient voice. We have developed a brief survey...

$70M US alliance to develop new cell therapies for blinding eye diseases building on FBC funded research

A new strategic research and development (R&D) alliance was announced on May 17, 2021 between BlueRock Therapeutics LP, FUJIFILM Cellular Dynamics Inc (FCDI) and Opsis Therapeutics LLC to develop new cell therapies...

New report reveals vision loss costs Canada almost $33 billion annually

Fighting Blindness Canada, partnering with the Canadian Council of the Blind and key partners, the Canadian Association of Optometrists and the Canadian Ophthalmological Society, commissioned new research, The Cost of Vision loss...